BusinessCrown Bioscience Inc. Announcing the 2017 Board of Directors Election ResultsBy Nasdaq OMXNov 9, 2017, 10:21 AM UTC
BusinessCrownBio Enhances Its European Capabilities with New Generation of Innovative Translational Models for Obesity and DiabetesBy Nasdaq OMXOct 10, 2017, 1:32 PM UTC
BusinessCrown Bioscience Names Dr. Leon Hall Vice President of Global Scientific ExcellenceBy Nasdaq OMXAug 22, 2017, 12:00 PM UTC
BusinessCrown Bioscience Announces Second Quarter Results, Appoints Dr. Yangzhou Wang as Sr. VP of Global OperationsBy Nasdaq OMXAug 14, 2017, 4:00 AM UTC
BusinessCrownBio Demonstrates Scientific Advancements in Metabolic Disease with a validated and improved translatable model for obesity and Type 2 Diabetes drug discoveryBy Nasdaq OMXJul 6, 2017, 12:00 PM UTC
BusinessThe Jackson Laboratory and Crown Bioscience Announce Global Pre-Clinical Research AgreementBy Nasdaq OMXJun 20, 2017, 1:00 PM UTC
